Actionable news
All posts from Actionable news
Actionable news in XLRN: Acceleron Pharma Inc.,

Acceleron Pharma's (XLRN) CEO John Knopf on Q3 2015 Results - Earnings Call Transcript


Welcome to Acceleron's Third Quarter Conference Call. [Operator Instructions]. I would like to introduce your host for today's conference Mr. Todd James, Senior Director of Corporate Communications at Acceleron. Sir, please begin.

Todd James - Senior Director, Corporate Communications

Thanks and welcome everyone to Acceleron's third quarter earnings conference call. The press release reporting our financial results in addition to the presentation for today's webcast can be accessed by going to the Investors and Media section of the corporate website at On the call today with prepared remarks are John Knopf, Chief Executive Officer, Steven Ertel, Chief Operating Officer, Matthew Sherman, Chief Medical Officer and Kevin McLaughlin, Chief Financial Officer.

As a reminder, we will make forward-looking statements regarding financial outlook in addition to regulatory and product development plans. These statements are subject to risks and uncertainties that may cause actual results to differ from those forecasted. A description of these risks can be found in our most recent form 10-Q on file with the SEC.

I would...